NovaBay Pharmaceuticals
NBY
NBY
14 hedge funds and large institutions have $290K invested in NovaBay Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Holders
14
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$108K | |
| 2 | +$37.5K | |
| 3 | +$35.3K | |
| 4 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
+$24.5K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$22.9K |
Top Sellers
| 1 | -$56.8K | |
| 2 | -$19.3K | |
| 3 | -$14.1K | |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$11.8K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5.76K |
